Edwards Lifesciences (EW) Non Operating Income (2009 - 2026)

Edwards Lifesciences has reported Non Operating Income for 18 years, with the latest figure at $6.6 million in Q2 2026.

• On a quarterly basis, Non Operating Income rose 160.0% year-over-year to $6.6 million in Q2 2026; TTM through Jun 2026 was -$31.4 million, a 119.9% decrease from a year earlier, with the FY2025 full-year figure at $8.7 million, down 94.86% from the prior year.
• Non Operating Income was $6.6 million for Q2 2026 at Edwards Lifesciences, up from -$18.6 million in the prior quarter.
• The five-year high for Non Operating Income was $77.5 million in Q4 2024, with the low at -$60.7 million in Q4 2025.
• Average Non Operating Income over 5 years is $14.0 million, with a median of $12.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income jumped 716.67% in 2022, then plunged 178.32% in 2025.
• Over 5 years, Non Operating Income stood at $13.7 million in 2022, then jumped by 48.91% to $20.4 million in 2023, then soared by 279.9% to $77.5 million in 2024, then slumped by 178.32% to -$60.7 million in 2025, then surged by 110.87% to $6.6 million in 2026.
• The last three Non Operating Income figures came in at $6.6 million (Q2 2026), -$18.6 million (Q1 2026), and -$60.7 million (Q4 2025), per Business Quant data.